SSA
EVH icon

Schonfeld Strategic Advisors’s Evolent Health EVH Stock Holding History

Schonfeld Strategic Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
20,447
-42,896
-68% -$164K ﹤0.01% 2292
2026
Q1 		$144K Buy
+63,343
New +$201K ﹤0.01% 1833
2025
Q4 		– Sell
-259,017
Closed -$2.19M – 2194
2025
Q3 		$2.19M Buy
+259,017
New +$2.51M 0.01% 985
2025
Q2 		– Sell
-50,204
Closed -$475K – 2179
2025
Q1 		$475K Buy
+50,204
New +$507K ﹤0.01% 1606
2024
Q3 		– Sell
-59,470
Closed -$1.14M – 2146
2024
Q2 		$1.14M Buy
59,470
+51,870
+683% +$1.32M 0.01% 1147
2024
Q1 		$249K Buy
+7,600
New +$243K ﹤0.01% 1719
2023
Q4 		– Sell
-25,300
Closed -$689K – 1971
2023
Q3 		$689K Sell
25,300
-5,300
-17% -$147K 0.01% 1130
2023
Q2 		$927K Sell
30,600
-70,900
-70% -$2.29M 0.01% 1009
2023
Q1 		$3.29M Buy
+101,500
New +$3.21M 0.03% 555
2022
Q4 		– Sell
-185,000
Closed -$6.65M – 2702
2022
Q3 		$6.65M Buy
185,000
+97,500
+111% +$3.43M 0.06% 438
2022
Q2 		$2.69M Buy
87,500
+25,600
+41% +$746K 0.03% 660
2022
Q1 		$2M Buy
61,900
+30,345
+96% +$795K 0.02% 740
2021
Q4 		$873K Buy
31,555
+20,855
+195% +$598K 0.01% 1003
2021
Q3 		$331K Sell
10,700
-7,856
-42% -$189K ﹤0.01% 1478
2021
Q2 		$392K Buy
+18,556
New +$372K ﹤0.01% 1317
2020
Q2 		– Sell
-17,900
Closed -$97K – 1331
2020
Q1 		$97K Buy
+17,900
New +$160K 0.01% 1006
2019
Q1 		– Sell
-70,000
Closed -$1.4M – 1086
2018
Q4 		$1.4M Buy
70,000
+20,000
+40% +$463K 0.05% 391
2018
Q3 		$1.42M Sell
50,000
-10,000
-17% -$239K 0.06% 358
2018
Q2 		$1.26M Buy
+60,000
New +$1.14M 0.07% 354
2017
Q4 		– Sell
-50,000
Closed -$890K – 769
2017
Q3 		$890K Buy
+50,000
New +$1.03M 0.08% 285

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Schonfeld Strategic Advisors's EVH Position: Q2 2026 in Review

Schonfeld Strategic Advisors reduced its Evolent Health (EVH) stake by 68% in Q2 2026, selling an estimated $164K and leaving 20,447 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Schonfeld Strategic Advisors first reported a position in EVH in Q3 2017 and has held it in 20 quarters since. The position peaked at $6.65M in Q3 2022. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Schonfeld Strategic Advisors held 20,447 shares of Evolent Health worth $111K as of Q2 2026.
  • Schonfeld Strategic Advisors sold 42,896 Evolent Health shares in Q2 2026, an estimated $164K.
  • Evolent Health made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2292 holding.
  • Schonfeld Strategic Advisors first reported a position in Evolent Health in Q3 2017 and has held it in 20 quarters since.
  • Schonfeld Strategic Advisors's Evolent Health position peaked at $6.65M in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.